Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs

A bipartisan group of senators is aiming to relieve that cost burden with the INSULIN Act, a bill to cap the cost of the lifesaving drug at $35 per month for Americans with private insurance plans. Chicago Tribune